Join the Liver Cell Biology SIG leadership to learn about the SIG's activities for this year, and to discuss potential future initiatives for next year.

University of Oslo

Massachusetts Institute of Technology

Hospital Universitario La Fe University of Valencia

U.S. Food and Drug Administration (FDA)

Uchealth Transplant Center

This scientific session focuses on novel experimental approaches and molecular insights into the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD), exploring potential therapeutic targets for its treatment.